Attovia Therapeutics share price logo

Attovia Therapeutics

NASDAQ: ATTO

as on

Attovia Therapeutics Stock Performance

as on January 1, 1970 at 11:00 am IST

  • $0.42
    $9.16

Attovia Therapeutics share price movements today

Previous Close
-
Open
-
Volume
-
52 Week Low - High
$0.42 - $9.16

Attovia Therapeutics Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Attovia Therapeutics Stock Fundamentals & Key Indicators

Check Attovia Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.8M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

7.9433

Return On Equity TTM

-164.96%

Attovia Therapeutics stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Attovia Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Attovia Therapeutics image
Attovia Therapeutics
BUY$6.8MNANA-9.17%NA

Analyst Recommendation on Attovia Therapeutics Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Attovia Therapeutics. Average target price of $15

Attovia Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Attovia Therapeutics.

What analysts predicted

100%UPSIDE

Target Price

$15

Current Price

$

Analyzed by

8 Analysts

Target

$15.00

Attovia Therapeutics target price $15, a slight upside of 100% compared to current price of $. According to 8 analysts rating.

Attovia Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Jun 2020
Sep 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Total Revenue
314
352
369
370
382
368
327
327
363
346
Gross Profit
298
334
348
349
353
346
305
305
333
311
Operating Income
-6
14
22
8
22
20
-365
-365
0
13
EBITDA
30
46
56
42
57
53
11
11
31
44
Interest Expense
16
18
18
24
22
18
27
27
20
13
Depreciation
28
30
30
30
28
30
43
30
31
30
Income Before Tax
-20
-10
-2
-19
-5
-4
-54
-54
-15
14
Income Tax Expense
-2
2
5
0
9
6
-10
-10
-3
13
Net Income
-18
-13
-7
-20
-14
-11
-43
-43
-12
1
Net Profit Margin
-5.83%
-3.71%
-2.14%
-5.44%
-3.85%
-3.17%
-13.36%
-13.36%
-3.32%
0.43%

Attovia Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2012
Dec 2013
Dec 2014
Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Total Revenue
2,290
2,341
2,298
1,965
1,757
1,921
1,818
1,707
1,412
1,449
Gross Profit
725
2,225
2,193
1,887
1,691
1,846
1,747
1,640
1,340
1,355
Operating Income
470
104
87
119
116
92
89
63
56
72
EBITDA
380
326
297
237
220
204
203
204
176
205
Interest Expense
72
117
135
75
59
78
45
68
69
91
Depreciation
-
-
-
-
-
104
95
140
120
133
Income Before Tax
-581
4
-23
72
8
-1
33
-44
-41
-84
Income Tax Expense
97
8
18
23
5
12
13
36
5
5
Net Income
-679
-4
-42
49
0
-16
18
-80
-46
-90
Net Profit Margin
-29.66%
-0.17%
-1.83%
2.50%
0.00%
-0.87%
1.02%
-4.73%
-3.31%
-6.22%

Attovia Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Sep 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Net Income
-10
-2
-19
-5
-4
-54
-54
-15
14
Operating Cash Flow
10
60
0
14
26
1
1
27
-1
Investing Cash Flow
-8
-10
-7
-18
-10
-14
-13
-4
-11
Financing Cash Flow
-21
-36
-14
-30
-14
0
0
-10
-18
Change in Cash
-10
12
-32
-22
-8
-16
-16
5
-36

Attovia Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2013
Dec 2014
Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Net Income
4
-23
72
8
-1
33
-44
-41
-84
Operating Cash Flow
99
135
36
141
114
81
46
128
42
Investing Cash Flow
-123
-149
-67
-75
-90
-41
-55
-38
-50
Financing Cash Flow
31
38
36
-62
-84
-33
5
0
-58
Change in Cash
13
-2
-27
10
-52
-8
-8
84
-80

Global Institutional Holdings in Attovia Therapeutics

Funds
Holdings
Millennium Management LLC
0%
HPS Investment Partners, LLC
0%
Farallon Capital Management, L.L.C.
0%
Morgan Stanley - Brokerage Accounts
0.57%
TWO SIGMA SECURITIES, LLC
0.2%
See all

About Attovia Therapeutics

Atento S.A., together with its subsidiaries, provides customer relationship management business process outsourcing services and solutions in Brazil, the Americas, Europe, the Middle East, and Africa. It offers a range of front and back-end services, including sales, customer care, technical support, collections, and back office. The company serves clients primarily in the telecommunications, financial services, consumer goods, retail, public administration, healthcare, travel, transportation, logistics, and technology and media sectors. It provides its services and solutions through digital channels, which include SMS, email, chats, social media and apps, and others, as well as through voice. The company was formerly known as Atento Floatco S.A. Atento S.A. was founded in 1999 and is based in Luxembourg.
OrganisationAttovia Therapeutics
Headquarters1, rue Hildegard Von Bingen, Luxembourg City, Luxembourg, 1282
IndustryProfessional & Commercial Services
CEOMr. Dimitrius Rogerio de Oliveira
E-voting on sharesClick here to vote

Key Management of Attovia Therapeutics

Name

Title

Mr. Hernan van Waveren

Director of Investor Relations

Ms. Virginia Beltramini Trapero

Chief Legal Officer & Sec. of the Board

Mr. Pablo Sanchez

Director of Marketing & ESG Director

Mr. Anil Bhalla

Exec. Chairman

Mr. Sergio Ribeiro Passos

Chief Financial Officer

Mr. Josh Ashby

Chief Delivery Officer & COO

Ms. Kiomara Hidalgo

Global Chief People Officer

Mr. Miguel Matey Marañón

Managing Director for Mexico & the North Region

Mr. Dimitrius Rogerio de Oliveira

CEO & Director

Mr. Gustavo Tasner

COO & South Regional Director

FAQs

What is Attovia Therapeutics's market capitalisation today?

Attovia Therapeutics market capitalisation is $0.00T as on .

How to invest in Attovia Therapeutics Stock (ATTO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Attovia Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Attovia Therapeutics Shares .

What is the minimum amount required to buy Attovia Therapeutics Stock (ATTO) from India?

Indian investors can start investing in Attovia Therapeutics (ATTO) shares with as little as ₹95.38 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Attovia Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Learn more about fractional shares .